Abstract
Abstract Introduction. Hepatitis B virus (HBV) is one of the major health threats causing cancer. Asian Americans are especially vulnerable to HBV infection risk compared to other racial/ethnic groups in America. New mHealth interventions have promising potential to save lives by increasing HBV screening among racial/ethnic minority groups, but its scope, range, and uptake among Asian Americans are not clear. This study aims to scope the literature describing the research of mHealth interventions on HBV screening among Asian Americans. Methods. A scoping systematic review search is conducted in PubMed and Embase. Eligible studies focus on Asian Americans aged 18 years or older who have participated in an mHealth Hepatitis B screening. All types of mHealth interventions on HBV are relevant (e.g., health apps and text messages). Studies not published in the English language will be excluded. Results. A review protocol is developed. Next. We will covert our search strategy to Embase, Medline, and other databases to get more records. At present, title and abstract screening are under development. After that, full-text screening, data extraction, data management, quality assessment, and data synthesis and analysis will be conducted. Initial results will be discussed. Potential impact. The results of this scoping and systematic review could improve our understanding of mHealth HBV screening use and uptake among Asian Americans and inform the development of a future intervention to encourage mHealth HBV screening for this patient population. In the long run, it could encourage the development of a future tailored mHealth intervention to facilitate the HBV screening uptake among Asian Americans Citation Format: Di Zhu, Yarra Zisman-Ilani, Stephanie Roth, Lin Zhu, Grace X. Ma. The effective of mHealth intervention on hepatitis B virus screening among Asian Americans: A scoping review [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr A131.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
